Medical devices, healthcare technology and the business of care
510(k) clearance · K261462

LANDMARK Total Knee System

Smith & Nephew, Inc. · Decision date Sep 8, 2026

MEDTECHLEDGER EXPLANATIONK261462

What did the FDA decide?

FDA records show a 510(k) premarket notification, K261462, for the LANDMARK Total Knee System, submitted by Smith & Nephew, Inc. The listed medical specialty is Orthopedic and the product code is MBH, which the source page describes as a semi-constrained patello/femorotibial knee prosthesis. The application was received on 05/04/2026 and decided on 09/08/2026.

The recorded decision is SESE, which for a 510(k) denotes clearance rather than PMA approval. The source does not state which components, materials, sizes or labeling changes distinguish this submission, nor does it identify a predicate device or summarize the review basis. No clearance statement text, indications, or clinical data are available here, so the scope of what was cleared remains unknown beyond the listed device name and classification fields.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 8, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261462
Regulatory pathway
510(k) premarket notification
Product code
MBH
Decision code
SESE
Decision date
Sep 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer.

Product code
MBH
FDA device class
2

FDA decision timeline

  1. K261462 received

    Application receipt date recorded by FDA.

  2. K261462 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MBH

Product / regulatory recordCompanyPathwayDecision dateSource
Corin, Ltd.510(k) clearanceSep 17, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Smith & Nephew, Inc.

Headquarters
Not reported
Brand website
smith-nephew.com
FDA applicant address
Memphis, TN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records